Top Markets
#1 ADO Protocol ADO Protocol +193.44%
#2 Islamic Coin Islamic Coin +155.40%
#3 GoPlus Security GoPlus Security +43.47%
#4 GAIB AID GAIB AID +24.67%
#5 Casper Network Casper Network +15.03%
#6 Verus Coin Verus Coin +13.64%
#7 SkyAI SkyAI +13.54%
#8 Starpower Starpower +12.35%
#9 o1.exchange o1.exchange +11.59%
#10 Ontology Gas Ontology Gas +10.82%
Coin of the day
ADO Protocol ADO Protocol
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Antisense Therapeutics Limited Antisense Therapeutics Limited

Antisense Therapeutics Limited

ANP
Rangering i aksjer #33640
Antisense Therapeutics Limited, an Australian company headquartered in Toorak... Antisense Therapeutics Limited, an Australian company headquartered in Toorak and founded in 2000, specializes in the research and advancement of innovative antisense pharmaceutical drugs. Its primary pipeline asset, ATL1102, is an antisense inhibitor designed to target CD49d, which is currently in Phase II clinical trials for treating various inflammatory conditions such as multiple sclerosis, Duchenne Muscular Dystrophy, and asthma. Another promising therapeutic in their portfolio is ATL1103, a second-generation antisense drug that aims to block growth hormone receptor expression, thereby lowering insulin-like growth factor-I levels in the blood, and has completed Phase II clinical trials for conditions stemming from excessive growth hormone action.
Aksjekurs
$0.03702159
Sist synkronisert: 2024-01-29
Markedsverdi
$7.21M
Endring (1 dag)
-3.08%
Endring (1 år)
0.00%
Land
AU
Handel Antisense Therapeutics Limited (ANP)

Kategori

Healthcare
Inntekter for Antisense Therapeutics Limited (ANP)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Antisense Therapeutics Limited er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Antisense Therapeutics Limited fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
MERCK Kommanditgesellschaft auf Aktien MERCK Kommanditgesellschaft auf Aktien
MERCK Kommanditgesellschaft auf Aktien
MER.SW
 - -
DE
Merck KGaA Merck KGaA
Merck KGaA
MRK.DE
 - -
DE
Takeda Pharmaceutical Company Limited Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited
4502.T
 - -
JP
Galderma Group AG Galderma Group AG
Galderma Group AG
GALD.SW
 - -
CH
Sun Pharmaceutical Industries Limited Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
SUNPHARMA.NS
 $6.61B -
IN